| Title: | Association between the difference in cystatin C and creatinine-based eGFR and risks of multiple cardiovascular diseases: a prospective cohort study |
| Journal: | Frontiers in Medicine |
| Published: | 17 Nov 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/41333795/ |
| DOI: | https://doi.org/10.3389/fmed.2025.1670059 |
| URL: | https://public-pages-files-2025.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1670059/pdf |
Publication 18903
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Background: The difference between cystatin C- and creatinine-based estimated glomerular filtration rate (eGFRdiff) is closely associated with various adverse outcomes. This study aims to comprehensively evaluate the association between eGFRdiff, all-cause mortality, and the risk of multiple cardiovascular-related diseases.</p>
Methods: This study analyzed data from 297,140 participants in the UK Biobank to assess the association between eGFRdiff, mortality, and the incidence of multiple cardiovascular-related diseases. eGFRdiff was classified into three groups: negative (< -15 mL/min/1.73 m2), intermediate (-15 to 15 mL/min/1.73 m2), and positive (≥ 15 mL/min/1.73 m2). Cox proportional hazards regression models were used to evaluate this association, while various sensitivity analyses were performed to assess its robustness.</p>
Results: During a mean follow-up of 13.1 years, the positive eGFRdiff group exhibited significantly lower mortality, cardiovascular disease (CVD) incidence, and the occurrence of CVD-related conditions. In the fully adjusted model, participants in the negative eGFRdiff group had a hazard ratio of 1.44 (95% confidence interval [CI], 1.40-1.49) for all-cause mortality, 1.49 (95% CI, 1.41-1.59) for CVD incidence, and 1.25 (95% CI, 1.22-1.27) for CVD mortality. The risk of all 10 CVD-related conditions was also significantly higher in the negative group, whereas the positive group exhibited significantly lower risks. For every 10 mL/min/1.73 m2 increase in eGFRdiff, the incidence of various diseases decreased by approximately 10-19%.</p>
Conclusion: eGFRdiff is significantly associated with increased risks of mortality, CVD incidence, and multiple CVD-related conditions. These findings underscore the critical need for developing targeted prevention strategies, particularly for populations with reduced eGFRdiff.</p>
8 Authors
- Zhiyu Qiao
- Xinyi Liu
- Hao Liu
- Suwei Chen
- Chengnan Li
- Yipeng Ge
- Haiou Hu
- Junming Zhu
1 Application
| Application ID | Title |
|---|---|
| 145937 | The interaction of type 2 diabetes mellitus and hypertension in aortic disease. |
Enabling scientific discoveries that improve human health